Molded body manufacturing method and molded body

By immersing calcium carbonate in a flowing phosphate ion solution, the method controls carbonic acid content, producing carbonated apatite with reduced carbonate content to prevent volume loss during bone formation.

JP2024159301APending Publication Date: 2024-11-08GC CORP
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2023075201
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Filing Date
2023-04-28
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Carbonate apatite, which is highly bioabsorbable, has a high carbonate content and may decrease in volume during bone formation.

Method used

A method involving immersing calcium carbonate in a flowing solution containing phosphate ions to control the carbonic acid content, converting it into carbonated apatite with controlled carbonate substitution, maintaining the shape and bioabsorbability.

Benefits of technology

The method produces carbonated apatite with a lower carbonate content, reducing the likelihood of volume decrease during bone formation while maintaining bioabsorbability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024159301000001_ABST
    Figure 2024159301000001_ABST
Patent Text Reader

Abstract

To provide carbonate apatite whose carbonic acid content is controlled.SOLUTION: A method for manufacturing a molded body includes immersing a molded body containing calcium carbonate in a solution containing a phosphate ion which flows.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a method for producing a molded article and the molded article. [Background technology]

[0002] In medical fields such as medicine and dentistry, autologous bone grafting to the defect or void is considered the first choice for repairing a wide range of bone defects or voids. However, harvesting autologous bone requires surgical invasion of healthy tissue, and there is a limit to the amount that can be harvested, so transplantation of bone substitute materials as a substitute for autologous bone is widely practiced.

[0003] In recent years, carbonate apatite granules and blocks have been developed as bone fillers, which have a composition similar to the inorganic components of bone and are bioabsorbable. Carbonate apatite has a structure in which part of hydroxyapatite is replaced with carbonate ions.

[0004] Methods for producing carbonate apatite include a method in which carbonate-containing apatite synthesized by a wet method is compressed under hydrostatic pressure and sintered at various temperatures, and a method in which a calcium carbonate precursor is immersed in a phosphate solution (see, for example, Patent Document 1). [Prior art documents] [Patent documents]

[0005] [Patent Document 1] Patent No. 4854300 Summary of the Invention [Problem to be solved by the invention]

[0006] Carbonate apatite, which is highly bioabsorbable, has a high carbon dioxide content and may lose volume during bone formation.

[0007] An object of the present invention is to provide a carbonate apatite having a controlled carbonate content. [Means for solving the problem]

[0008] One aspect of the present invention is a method for producing a formed body, comprising immersing a formed body containing calcium carbonate in a solution containing flowing phosphate ions. Effect of the Invention

[0009] According to one aspect of the present invention, it is possible to provide carbonate apatite having a controlled carbonate content. [Brief description of the drawings]

[0010] [Figure 1] FIG. 1 is a schematic diagram showing an example of an apparatus for producing carbonate apatite. [Diagram 2] FIG. 4 is a schematic diagram showing another example of an apparatus for producing carbonate apatite. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0011] Hereinafter, an embodiment of the present invention will be described.

[0012] <Method of manufacturing molded body> In the method for producing a molded body according to the embodiment, a molded body containing calcium carbonate (CaCO3) is mixed with flowing phosphate ions (PO4 3- ) in a solution containing

[0013] In this specification, a molded body containing calcium carbonate refers to a molded body made of a component containing calcium carbonate (CaCO3). The form of the molded body containing calcium carbonate is not particularly limited, and may be granules, blocks, etc.

[0014] "Immersing in a solution containing phosphate ions" means phosphate ions (PO4 3- ) source. 3-) source is not particularly limited, but may be, for example, an aqueous solution of phosphoric acid, a phosphate, or the like. Specific examples include solutions of phosphoric acid or a phosphate, such as triammonium phosphate, tripotassium phosphate, trisodium phosphate, disodium ammonium phosphate, diammonium sodium phosphate, ammonium dihydrogen phosphate, potassium dihydrogen phosphate, sodium dihydrogen phosphate, trimagnesium phosphate, sodium ammonium hydrogen phosphate, diammonium hydrogen phosphate, dipotassium hydrogen phosphate, disodium hydrogen phosphate, magnesium hydrogen phosphate, tridiacetyl phosphate, diphenyl phosphate, dimethyl phosphate, cellulose phosphate, ferrous phosphate, ferric phosphate, tetrabutylammonium phosphate, copper phosphate, triethyl phosphate, tricresyl phosphate, tristrimethylsilyl phosphate, triphenyl phosphate, tributyl phosphate, trimethyl phosphate, guanidine phosphate, and cobalt phosphate. Among these, an aqueous solution of a phosphate is preferred, and an aqueous solution of disodium hydrogen phosphate (Na2HPO4) is more preferred.

[0015] Phosphate ion (PO4 3- The temperature (reaction temperature) of the solution containing ) is not particularly limited, but is preferably 30° C. or higher, more preferably 40° C. or higher, and even more preferably 50° C. or higher. The upper limit of the temperature is not limited, but the upper limit of the practicable temperature is 200° C. or lower, preferably 150° C. or lower, and more preferably 100° C. or lower. When the reaction temperature is 30° C. or higher, the reaction can be completed quickly.

[0016] In addition, phosphate ions (PO4 3- When the formed body containing calcium carbonate is immersed in a solution containing phosphate ion source, the molar ratio of the formed body containing calcium carbonate to the phosphate ion source may be adjusted. The molar ratio of the phosphate ion source to calcium carbonate is, for example, preferably 1 to 100, more preferably 2 to 90, and even more preferably 5 to 80. When the molar ratio of the phosphate ion source to calcium carbonate is 1 or more, the apatitization reaction (dissolution-precipitation reaction) is easily promoted, and when it is 100 or less, the generation of hydroxyapatite not containing carbonate groups can be suppressed.

[0017] The form of the flowing solution is not particularly limited, but may be, for example, a stirred solution, a circulating solution, or the like.

[0018] FIG. 1 shows an example of an apparatus for carrying out the method for producing a molded body according to the present embodiment. In this example, a sieve 3 is placed in a reaction vessel 1 in a state where it is floating above the bottom of the reaction vessel 1, a stirrer 4 (e.g., a magnetic stirrer) is rotatably installed on the bottom of the reaction vessel 1, granules of a molded body 5 containing calcium carbonate are placed in the sieve 3, and phosphate ions (PO4 3- 1, a stirring bar 4 is placed so as not to come into contact with the molded body 5.

[0019] The formed body 5 containing calcium carbonate (CaCO3) can be produced in any manner. For example, calcium hydroxide (Ca(OH)2) is mixed with water to which an organic binder has been added to prepare a slurry, and the slurry is then hardened and heated to produce calcium oxide (CaO).

[0020] When the obtained calcium oxide (CaO) is left in a CO2 atmosphere of a specified temperature, humidity, and concentration for a specified period of time, a complex of calcium hydroxide (Ca(OH)2) and calcium carbonate (CaCO3) is produced. When this is immersed in a sodium bicarbonate (NaHCO3) solution of a specified concentration and left to stand at a specified temperature for a specified period of time, porous calcium carbonate (CaCO3) is produced.

[0021] In this example, the thus obtained formed body of calcium carbonate (CaCO3) is used.

[0022] Phosphate ion (PO4 3- The solution 2 containing ) is not particularly limited, and examples thereof include an aqueous solution of phosphoric acid (H3PO4), an aqueous solution of a phosphate, etc. Among them, an aqueous solution of a phosphate is preferable, and an aqueous solution of disodium hydrogen phosphate (Na2HPO4) is more preferable.

[0023] Phosphate ion (PO4 3-The concentration of the solution 2 containing phosphate ions (PO4 3- When the solution 2 containing the aqueous solution of disodium hydrogen phosphate (Na2HPO4), the concentration is, for example, 0.1N or more, preferably 0.3N or more, and more preferably 0.5N or more. When the concentration is 0.1N or more, the apatitization reaction (dissolution-precipitation reaction) is facilitated. Although there is no upper limit to the concentration, it is, for example, 3N or less, preferably 2N or less, and more preferably 1.5N or less, from the viewpoint of ease of preparation.

[0024] The rotation speed of the stirrer 4 is not particularly limited, but is, for example, 10 rpm to 2000 rpm, preferably 100 rpm to 1000 rpm, and more preferably 200 rpm to 800 rpm. If the rotation speed is 10 rpm or more, the generation of a concentration gradient of ions in the solution is suppressed, and if it is 2000 rpm or less, the compacts can be agitated to suppress collisions between the compacts.

[0025] Fig. 2 is a schematic diagram showing another example of an apparatus for producing a molded body of this embodiment. In Fig. 2, the description of the parts common to Fig. 1 will be omitted. In the example of Fig. 2, an upside-down sieve 6 is placed on the bottom surface of a reaction vessel 1, and a stirrer 4 is placed above the sieve 6. In the example of Fig. 2, the stirrer 4 is also placed so as not to come into contact with the molded body 5.

[0026] In this embodiment, by using such a manufacturing method for a molded body, the molded body of calcium carbonate (CaCO3) is immersed in the flow of phosphate ions (PO4 3- ) while maintaining its shape, it can be dissolved in a solution containing calcium ions (Ca 2+ ) and carbonate ions (CO3 2- ) and the dissociated calcium ions (Ca 2+ ) and carbonate ions (CO3 2- ) and phosphate ions (PO4 3- ) or hydroxide ions (OH - ) reacts and precipitates to obtain carbonate apatite.

[0027] As a result, while maintaining the shape of the calcium carbonate-containing molded body, the calcium carbonate is converted into A-type carbonate apatite, B-type carbonate apatite, or a mixture of A-type carbonate apatite and B-type carbonate apatite.

[0028] Here, A-type carbonate apatite has the chemical formula Ca 10 The hydroxide ion (OH) in hydroxyapatite is represented by (PO4)6(OH)2. - ) is at least partially carbonate ion (CO3 2- ) is substituted with . Type B carbonate apatite has the chemical formula Ca 10 The phosphate ion (PO4 3- ) is at least partially carbonate ion (CO3 2- ) is substituted with . Furthermore, a mixture of A-type carbonate apatite and B-type carbonate apatite is a carbonate apatite in which A-type carbonate apatite and B-type carbonate apatite are randomly mixed.

[0029] As a result, in this embodiment, the obtained molded body can have a reduced carbon dioxide content in the carbonated apatite while maintaining the shape of the molded body containing calcium carbonate.

[0030] In addition, in the method for producing the molded body of this embodiment, phosphate ions (PO4 3- ) flows, the carbonate ions (CO3 2- ) concentration gradient does not occur. Therefore, calcium ions (Ca 2+ ) and carbonate ions (CO3 2- ) is not inhibited, and the conversion of calcium carbonate to carbonate apatite is sufficiently carried out, so that calcium carbonate is unlikely to remain.

[0031] In addition, the molding containing calcium carbonate is subjected to the action of flowing phosphate ions (PO4 3- ) on the surface of the calcium carbonate-containing molded body, dissociated carbonate ions (CO32- ) concentration decreases, so the phosphate ion (PO4 3- In comparison with the case where the solution containing the hydrate does not flow (is left to stand), carbonated apatite with a lower carbonate content can be obtained. As a result, according to the method for producing a molded product of the present embodiment, by delaying the effect of bioabsorbability while maintaining it, carbonated apatite that is less likely to decrease in volume during bone formation can be obtained.

[0032] <Molded body> The molded body of this embodiment is a carbonate apatite molded body formed from any one of A-type carbonate apatite, B-type carbonate apatite, and a mixture of A-type carbonate apatite and B-type carbonate apatite. Such a molded body can be manufactured by the above-mentioned manufacturing method of a molded body according to this embodiment.

[0033] A-type carbonate apatite has the chemical formula Ca 10 Hydroxyl groups or hydroxide ions (OH) in hydroxyapatite, represented by (PO4)6(OH)2 - ) to carbonate groups or carbonate ions (CO3 2- ) is a carbonate apatite substituted with . Type B carbonate apatite has the chemical formula Ca 10 The phosphate group or phosphate ion (PO4 3- At least a portion of the carbonic acid group or carbonate ion (CO 2- ) is substituted with . Furthermore, a mixture of A-type carbonate apatite and B-type carbonate apatite is a carbonate apatite in which A-type carbonate apatite and B-type carbonate apatite are randomly mixed.

[0034] In addition, A-type carbonate apatite contains hydroxide ions (OH - ) is at least partially carbonate ion (CO3 2- ) is replaced by phosphate ion (PO4 3- ) is partly carbonate ion (CO3 2- ) may be substituted. Furthermore, A-type carbonate apatite is a type of carbonate apatite that is substituted with carbonate ions (CO3 2- ), calcium ions (Ca2+ ), phosphate ion (PO4 3- ), or hydroxide ion (OH - ) may be partially substituted with other ions.

[0035] In addition, B-type carbonate apatite contains phosphate ions (PO4 3- ) is at least partially carbonate ion (CO3 2- ) is replaced by hydroxide ion (OH - ) is partly carbonate ion (CO3 2- ) may be substituted. Furthermore, B-type carbonate apatite is 2- ), calcium ions (Ca 2+ ), phosphate ion (PO4 3- ), or hydroxide ion (OH - ) may be partially substituted with other ions.

[0036] The molded body of this embodiment is thus formed from any one of A-type carbonate apatite, B-type carbonate apatite, and a mixture of A-type carbonate apatite and B-type carbonate apatite, and is therefore low in crystallinity and low in carbonate content. Therefore, the molded body of this embodiment maintains bioabsorbability due to its low crystallinity, while the low carbonate content delays the effect of bioabsorbability, and therefore is less likely to lose volume during bone formation.

[0037] The molded body of this embodiment has a crystallinity of 85% or less, preferably 50% to 85%, and more preferably 78% to 84% as measured by powder X-ray diffraction. It is considered that the lower the crystallinity of the carbonate apatite molded body, the higher its bioabsorbability and the more preferable it is. In particular, if the crystallinity is 85% or less, the lattice arrangement becomes irregular, making it easier for cells to decompose and absorb the material (high bioabsorbability).

[0038] In this specification, powder X-ray diffraction measurement is a method in which a powder sample is irradiated with X-rays, forcing electrons in the sample to vibrate, and the diffraction intensity due to coherent scattered X-rays generated is measured for each diffraction angle.

[0039] The crystallinity measured by powder X-ray diffraction measurement was calculated using the "profile fitting method (or profile fitting method)". Specifically, the crystallinity is calculated from the diffraction results from the crystalline region in the sample in the powder X-ray diffraction pattern according to the following formula (1).

[0040]

number

[0041] Furthermore, the molded product of this embodiment has a net strength at 2θ=31.9° measured by powder X-ray diffraction of 100 or less, preferably 85 or less, and more preferably 70 or less. Also, the net strength at 2θ=32.1° measured by powder X-ray diffraction of 95 or less, preferably 85 or less, and more preferably 75 or less.

[0042] In this specification, the net intensity in powder X-ray diffraction measurement is the X-ray intensity at a peak angle indicating the presence of a metal element in a sample minus the background intensity.

[0043] In the molded body of this embodiment, as described above, the crystallinity is 85% or less in the powder X-ray diffraction measurement, so that the lattice arrangement becomes irregular, and the cells can easily decompose and absorb the material (bioabsorbability is increased). In addition, a carbonate apatite molded body having a net strength of 100 or less at 2θ=31.9° has a low carbonic acid content and a slower bioabsorption rate, so that the volume is less likely to decrease during bone formation. In addition, a carbonate apatite molded body having a net strength of 95 or less at 2θ=32.1° also has a low carbonic acid content and a slower bioabsorption rate, so that the volume is less likely to decrease during bone formation.

[0044] In the shaped body of this embodiment, the content of carbon dioxide contained in the carbonate apatite shaped body is not particularly limited, but is preferably 9% by mass or less, more preferably 7% by mass or less, and even more preferably 5% by mass or less. The lower limit of the carbon dioxide content is not limited, but the lower limit of the feasible carbon dioxide content is 0.1% by mass or more, preferably 1% by mass or more, and more preferably 2% by mass or more.

[0045] In the molded body of this embodiment, the carbonate content is 9% by mass or less, so that the carbonate apatite has a low carbonate content and is less likely to lose volume during bone formation.

[0046] The formed body of the present embodiment preferably does not substantially contain calcium carbonate. Substantially not containing calcium carbonate means that calcium carbonate is not actively contained, and the allowable content of calcium carbonate in the carbonate apatite formed body is 1 mass % or less, preferably 0.1 mass % or less, and more preferably 0.01 mass % or less.

[0047] As described above, when a carbonate apatite molded body is produced by the method for producing a molded body of the present embodiment, a molded body containing calcium carbonate is used as a raw material for the carbonate apatite molded body, so that calcium carbonate may remain in the obtained carbonate apatite molded body.

[0048] However, in the above-mentioned method for producing a molded body, phosphate ions (PO4 3- ) flows, the phosphate ions (PO4 3- ) concentration gradient does not occur. Therefore, calcium ions (Ca 2+ ) and carbonate ions (CO3 2- ) is not inhibited, and the conversion of calcium carbonate to carbonate apatite is sufficiently carried out, so that calcium carbonate is unlikely to remain.

[0049] As described above, when a molded body containing calcium carbonate (CaCO3) is porous, calcium carbonate is dissolved in calcium ions (Ca 2+ ) and carbonate ions (CO3 2- ) and phosphate ions (PO4 3- From this viewpoint, when the formed body containing calcium carbonate (CaCO3) is a porous body, the conversion from calcium carbonate to carbonate apatite is sufficiently carried out.

[0050] In this way, since the molded body of this embodiment does not contain calcium carbonate, it is possible to suppress an increase in crystallinity due to remaining calcium carbonate. Also, the content of carbonic acid in the carbonate apatite molded body is suppressed, and the content of carbonic acid in the carbonate apatite molded body is low. Therefore, the molded body of this embodiment is unlikely to lose volume during bone formation by delaying the effect while maintaining high bioabsorbability.

[0051] In the present embodiment, the form of the shaped body is not particularly limited, but is preferably a granule or a block. When the carbonate apatite shaped body is in the form of a granule or a block, it is easily applicable as a bone filling material. EXAMPLES

[0052] Examples of the present invention will be described below, but the present invention is not limited to these examples.

[0053] <Preparation of calcium carbonate molded body (raw material)> Calcium hydroxide (Ca(OH)2) was mixed with water to which an organic binder had been added to prepare a slurry, and the slurry was hardened and heated to a temperature of 1100°C at a heating rate of 367°C / h for 3 hours, and then allowed to cool naturally to obtain a calcium oxide (CaO) molded body. This calcium oxide (CaO) molded body was left for 2 days at 28°C in a 10% CO2 atmosphere and 95% RH to obtain a molded body (block) containing calcium hydroxide (Ca(OH)2) and calcium carbonate (CaCO3). This molded body (block) was immersed in a 0.5N aqueous solution of sodium bicarbonate (NaHCO3) and left to stand at 60°C for 7 days to obtain a calcium carbonate (CaCO3) block. The obtained calcium carbonate (CaCO3) block was porous. This was processed into granules (20 mL of granules per 1 g).

[0054] <Preparation of carbonate apatite molded body (test specimen)> As test specimens, carbonate apatite molded bodies (blocks) were prepared under the conditions of Examples 1 to 3 and Comparative Examples 1, 2, and 1 shown below. As shown in Fig. 1, a sieve 3 containing the obtained calcium carbonate (CaCO3) block granules (molded body 5) was placed in a reaction vessel 1 containing an aqueous solution (solution 2) of disodium hydrogen phosphate (Na2HPO4) in a state where it was floating above the bottom of the reaction vessel 1, and a magnetic stirrer (stirring bar 4) was rotatably installed on the bottom of the reaction vessel 1 so as not to come into contact with the molded body 5.

[0055] [Example 1] The concentration of disodium hydrogen phosphate (Na2HPO4) in the reaction vessel 1 (solution 2) is expressed as calcium ion (Ca 2+ ) and phosphate ion (PO4 3- The molar ratio of disodium hydrogen phosphate (NaHPO4) was adjusted to 1:20. The aqueous solution of disodium hydrogen phosphate (NaHPO4) (solution 2) in reaction vessel 1 was stirred at a magnetic stirrer speed of 500 rpm while maintaining the reaction temperature at 60°C for 2 hours to obtain a porous carbonate apatite compact. The conditions are shown in Table 1.

[0056] [Example 2] The concentration of disodium hydrogen phosphate (Na2HPO4) in the reaction vessel 1 (solution 2) is expressed as calcium ion (Ca 2+ ) and phosphate ion (PO4 3- ) was adjusted to a molar ratio of 1:30, and a porous carbonate apatite molded body was obtained in the same manner as in Example 1. The conditions are shown in Table 1.

[0057] [Example 3] The concentration of disodium hydrogen phosphate (Na2HPO4) in the reaction vessel 1 (solution 2) is expressed as calcium ion (Ca 2+ ) and phosphate ion (PO4 3- ) was adjusted to a molar ratio of 1:60, and a porous carbonate apatite molded body was obtained in the same manner as in Example 1. The conditions are shown in Table 1.

[0058] [Comparative Example 1] The concentration of disodium hydrogen phosphate (Na2HPO4) in the reaction vessel 1 (solution 2) is expressed as calcium ion (Ca 2+ ) and phosphate ion (PO4 3- A porous carbonate apatite compact was obtained in the same manner as in Example 1, except that the aqueous solution of disodium hydrogen phosphate (NaHPO) (solution 2) in reaction vessel 1 was left to stand without stirring, and the obtained compact was then fired at 550°C for 10 hours. The conditions are shown in Table 1.

[0059] [Comparative Example 2] Except for not firing the compact, a porous carbonate apatite compact was obtained in the same manner as in Comparative Example 1. The conditions are shown in Table 1.

[0060] [Powder X-ray diffraction measurement] The crystallinity and net strength of the powdered samples obtained from Examples 1 to 3 and Comparative Examples 1 and 2 were calculated by powder X-ray diffraction measurement using a measuring device (all-in-one XRD device manufactured by Empyrean). The measurement conditions were Tension: 45 kV, Current: 40 mA, and measurement range: 2θ = 10.0° to 60.0°.

[0061] [Crystallization degree] Using the "profile fitting method (or profile fitting method)", the crystallinity was calculated from the diffraction results from the crystalline regions in the sample in the powder X-ray diffraction pattern according to the above formula (1). The results of Examples 1 to 3 are shown in Table 2, and the results of Comparative Examples 1 and 2 are shown in Table 4.

[0062] [Net Strength] The net intensity was calculated by subtracting the background intensity from the X-ray intensity at the peak angle indicating the presence of a metal element in the sample. The results of Examples 1 to 3 are shown in Table 2, and the results of Comparative Examples 1 and 2 are shown in Table 4.

[0063] [Table 1]

[0064] [Table 2]

[0065] [Table 3]

[0066] [Table 4]

[0067] As seen from Tables 1 and 2, in Examples 1 to 3, the crystallinity was 85% or less, the net strength at 2θ=31.9° was 100 or less, and the net strength at 2θ=32.1° was 95 or less in the powder X-ray diffraction measurement.

[0068] On the other hand, from Tables 3 and 4, in Comparative Examples 1 and 2, the net strength at 2θ=31.9° exceeded 100 in powder X-ray diffraction measurement, and furthermore in Comparative Example 1, the net strength at 2θ=32.1° exceeded 95.

[0069] From the above, the calcium carbonate-containing molding is immersed in a solution containing flowing phosphate ions, and the phosphate ions (PO4 3- It was found that compared to when the solution containing ammonium nitrate does not flow (when left to stand), carbonated apatite with a low carbonate content can be obtained while maintaining low crystallinity (Examples 1 to 3).

[0070] The above disclosed embodiments include, for example, the following aspects.

[0071] (Appendix 1) A formed body containing calcium carbonate is immersed in a solution containing flowing phosphate ions. A method for producing a molded body.

[0072] (Appendix 2) Chemical formula Ca 10 The hydroxide ion (OH) in hydroxyapatite is represented by (PO4)6(OH)2. - ) to carbonate ions (CO3 2- ) in the hydroxyapatite, and 3- ) to carbonate ions (CO3 2- ) or a mixture of the A-type carbonate apatite and the B-type carbonate apatite.

[0073] (Appendix 3) In powder X-ray diffraction measurement, the crystallinity is 85% or less and the net intensity at 2θ=31.9° is 100 or less. Attachment 2. A molded article according to claim 2.

[0074] (Appendix 4) In powder X-ray diffraction measurement, the crystallinity is 85% or less and the net intensity at 2θ=32.1° is 95 or less. Attachment 2 or 3. A molded body according to claim 2.

[0075] (Appendix 5) The carbon dioxide content is 9% by mass or less. 5. A molded article according to any one of claims 2 to 4.

[0076] (Appendix 6) Substantially free of calcium carbonate; 6. A molded body according to any one of claims 2 to 5.

[0077] (Appendix 7) It is a granule or a block. 7. A molded body according to any one of claims 2 to 6.

[0078] Although an embodiment of the present invention has been described above, the present invention is not limited to a specific embodiment, and various modifications and changes are possible within the scope of the invention described in the claims. [Explanation of symbols]

[0079] 1 Reaction vessel 2 solution 3 sieve 4 Stirring bar 5. Molded bodies (granules) containing calcium carbonate 6 sieve

Claims

1. A formed body containing calcium carbonate is immersed in a solution containing flowing phosphate ions. A method for producing a molded body.

2. Chemical formula Ca 10 (P.O. 4 ) 6 (OH) 2 The hydroxide ion (OH - ) to carbonate ions (CO 3 2- A type carbonate apatite in which phosphate ions (PO 4 3- ) to carbonate ions (CO 3 2- ) or a mixture of said A-type carbonate apatite and said B-type carbonate apatite.

3. In powder X-ray diffraction measurement, the crystallinity is 85% or less and the net intensity at 2θ = 31.9 ° is 100 or less. The molded article according to claim 2.

4. In powder X-ray diffraction measurement, the crystallinity is 85% or less and the net intensity at 2θ=32.1° is 95 or less. The molded article according to claim 2.

5. The carbon dioxide content is 9% by mass or less. The molded article according to claim 2.

6. Substantially free of calcium carbonate; The molded article according to claim 2.

7. It is a granule or a block. The molded article according to any one of claims 2 to 6.

Citation Information

Patent Citations

  • Natural bone substitution type artificial bone and its manufacture

    JP1995275343A

  • Calcium carbonate composition for medical use, compositions for medical use related with the same and method for producing these

    JP2021037281A

  • JP1973054300A